These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 34168615)

  • 21. Implications of Gut Microbiota in Complex Human Diseases.
    Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
    Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
    Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development.
    Chen B; Zeng G; Sun L; Jiang C
    Sci China Life Sci; 2024 May; 67(5):854-864. PubMed ID: 38265598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diet and gut microbiota: two sides of the same coin?].
    Schiumerini R; Pasqui F; Festi D
    Recenti Prog Med; 2018 Jan; 109(1):59-68. PubMed ID: 29451524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Gelatinized Wheat Starch and High Salt Diet on Gut Microbiota and Metabolic Disorder.
    Do MH; Lee HB; Lee E; Park HY
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31979147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review.
    Kwao-Zigah G; Bediako-Bowan A; Boateng PA; Aryee GK; Abbang SM; Atampugbire G; Quaye O; Tagoe EA
    Cancer Control; 2024; 31():10732748241263650. PubMed ID: 38889965
    [No Abstract]   [Full Text] [Related]  

  • 31. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood.
    Dai X; Guo Z; Chen D; Li L; Song X; Liu T; Jin G; Li Y; Liu Y; Ajiguli A; Yang C; Wang B; Cao H
    Gut Microbes; 2020 Jul; 11(4):1043-1063. PubMed ID: 32228300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.
    Xu F; Yu Z; Liu Y; Du T; Yu L; Tian F; Chen W; Zhai Q
    Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-microbial interactions in metabolic diseases: from diet to immunity.
    Lee JH; Park JH
    J Microbiol; 2022 Jun; 60(6):561-575. PubMed ID: 35511325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms.
    Bakhshimoghaddam F; Alizadeh M
    Clin Nutr ESPEN; 2021 Aug; 44():61-68. PubMed ID: 34330514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
    Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases.
    Desselberger U
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Cristofori F; Dargenio VN; Dargenio C; Miniello VL; Barone M; Francavilla R
    Front Immunol; 2021; 12():578386. PubMed ID: 33717063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health.
    Fassarella M; Blaak EE; Penders J; Nauta A; Smidt H; Zoetendal EG
    Gut; 2021 Mar; 70(3):595-605. PubMed ID: 33051190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.